Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Amortization of Deferred Charges: 2020-2025

Historic Amortization of Deferred Charges for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2025 value amounting to $330,000.

  • Benitec Biopharma's Amortization of Deferred Charges rose 60.00% to $104,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $330,000, marking a year-over-year increase of 28.91%. This contributed to the annual value of $330,000 for FY2025, which is 28.91% up from last year.
  • Benitec Biopharma's Amortization of Deferred Charges amounted to $330,000 in FY2025, which was up 28.91% from $256,000 recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's Amortization of Deferred Charges ranged from a high of $330,000 in FY2025 and a low of $193,000 during FY2021.
  • Its 3-year average for Amortization of Deferred Charges is $277,000, with a median of $256,000 in 2024.
  • Data for Benitec Biopharma's Amortization of Deferred Charges shows a peak YoY climbed of 28.91% (in 2025) over the last 5 years.
  • Over the past 5 years, Benitec Biopharma's Amortization of Deferred Charges (Yearly) stood at $193,000 in 2021, then rose by 16.58% to $225,000 in 2022, then climbed by 8.89% to $245,000 in 2023, then grew by 4.49% to $256,000 in 2024, then grew by 28.91% to $330,000 in 2025.